These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells. Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023 [TBL] [Abstract][Full Text] [Related]
46. Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. Honoki K; Fujii H; Kubo A; Kido A; Mori T; Tanaka Y; Tsujiuchi T Oncol Rep; 2010 Aug; 24(2):501-5. PubMed ID: 20596639 [TBL] [Abstract][Full Text] [Related]
47. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition. Te Kronnie G; Timeus F; Rinaldi A; Crescenzio N; Spinelli M; Rosolen A; Ricotti E; Basso G Int J Mol Med; 2004 Sep; 14(3):373-82. PubMed ID: 15289888 [TBL] [Abstract][Full Text] [Related]
48. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma. Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460 [TBL] [Abstract][Full Text] [Related]
49. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells. Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696 [TBL] [Abstract][Full Text] [Related]
50. TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models. Guiho R; Biteau K; Grisendi G; Taurelle J; Chatelais M; Gantier M; Heymann D; Dominici M; Redini F Int J Cancer; 2016 Dec; 139(12):2802-2811. PubMed ID: 27558972 [TBL] [Abstract][Full Text] [Related]
51. The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer. Dyshlovoy SA; Menchinskaya ES; Venz S; Rast S; Amann K; Hauschild J; Otte K; Kalinin VI; Silchenko AS; Avilov SA; Alsdorf W; Madanchi R; Bokemeyer C; Schumacher U; Walther R; Aminin DL; Fedorov SN; Shubina LK; Stonik VA; Balabanov S; Honecker F; von Amsberg G Int J Cancer; 2016 May; 138(10):2450-65. PubMed ID: 26695519 [TBL] [Abstract][Full Text] [Related]
52. Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors. Loganathan SN; Tang N; Holler AE; Wang N; Wang J Mol Cancer Ther; 2019 May; 18(5):929-936. PubMed ID: 30926641 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA. Perez M; Muñoz-Galván S; Jiménez-García MP; Marín JJ; Carnero A Oncotarget; 2015 Dec; 6(38):40557-74. PubMed ID: 26528855 [TBL] [Abstract][Full Text] [Related]
54. Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening. Grohar PJ; Woldemichael GM; Griffin LB; Mendoza A; Chen QR; Yeung C; Currier DG; Davis S; Khanna C; Khan J; McMahon JB; Helman LJ J Natl Cancer Inst; 2011 Jun; 103(12):962-78. PubMed ID: 21653923 [TBL] [Abstract][Full Text] [Related]
55. Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance. Kim Y; Kobayashi E; Kubota D; Suehara Y; Mukaihara K; Akaike K; Ito A; Kaneko K; Chuman H; Kawai A; Kitano S Oncotarget; 2016 Oct; 7(43):70832-70844. PubMed ID: 27683125 [TBL] [Abstract][Full Text] [Related]
56. Novel agents in development for pediatric sarcomas. Hughes DP Curr Opin Oncol; 2009 Jul; 21(4):332-7. PubMed ID: 19444103 [TBL] [Abstract][Full Text] [Related]
57. Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway. Li T; Zhang Q; Zhang J; Yang G; Shao Z; Luo J; Fan M; Ni C; Wu Z; Hu X BMC Cancer; 2014 Feb; 14():96. PubMed ID: 24529079 [TBL] [Abstract][Full Text] [Related]
58. Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation. Al-Sharif I; Remmal A; Aboussekhra A BMC Cancer; 2013 Dec; 13():600. PubMed ID: 24330704 [TBL] [Abstract][Full Text] [Related]
59. CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin. Guerzoni C; Fiori V; Terracciano M; Manara MC; Moricoli D; Pasello M; Sciandra M; Nicoletti G; Gellini M; Dominici S; Chiodoni C; Fornasari PM; Lollini PL; Colombo MP; Picci P; Cianfriglia M; Magnani M; Scotlandi K Clin Cancer Res; 2015 Jan; 21(1):146-56. PubMed ID: 25501132 [TBL] [Abstract][Full Text] [Related]
60. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells. Chang YW; Singh KP PLoS One; 2017; 12(3):e0174227. PubMed ID: 28323900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]